SoCal's Vical Terminates 54% of Workforce to Focus Resources on Two Clinical Programs Post author:Sam Post published:January 30, 2018 Post category:BioPharma Vical announced its restructuring late Tuesday. Source: BioSpace You Might Also Like 4 Top-Performing S&P 500 Biotech Stocks of 2017 December 27, 2017 It's Official: BiOptix Names New CEO April 10, 2017 2 Biotechs With the Potential of Doubling Investors' Cash February 14, 2018